Revenue
No reported data
LeonaBio, Inc. (LONA)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Research & development | $17.5M | $70.7M | $93.8M | $61.5M | $42.8M | $13.3M | $3.8M |
| Operating income | −$102.3M | −$100.9M | −$125.5M | −$104.0M | −$64.0M | −$20.0M | −$5.4M |
| Net income | −$105.6M | −$96.9M | −$117.7M | −$95.6M | −$54.9M | −$20.0M | −$5.2M |
| Basic EPSper diluted share | -$24.70 | -$25.19 | -$3.09 | -$2.53 | -$1.49 | -$1.67 | -$1.45 |
| Diluted EPSper diluted share | -$24.70 | -$25.19 | -$3.09 | -$2.53 | -$1.49 | -$1.67 | -$1.45 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 4, 2026Form 4 | Renninger RobertCHIEF FINANCIAL OFFICER | SellCommon Stock | 906 | $5.37 | $4.9K | 15.9K |
| Mar 4, 2026Form 4 | Worthington MarkGENERAL COUNSEL and CCO | SellCommon Stock | 1.3K | $5.37 | $7.1K | 18.4K |
| Mar 4, 2026Form 4 | CHURCH KEVINCHIEF SCIENTIFIC OFFICER | SellCommon Stock | 1.4K | $5.37 | $7.3K | 25.2K |
| Mar 4, 2026Form 4 | San Martin JavierCHIEF MEDICAL OFFICER | SellCommon Stock | 1.7K | $5.37 | $9.2K | 15.9K |
| Mar 4, 2026Form 4 | Litton Mark JamesPRESIDENT and CEO | SellCommon Stock | 5.2K | $5.37 | $27.7K | 57.9K |